Propanc Biopharma, Inc. Quarterly Return On Assets in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Propanc Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2012 to Q3 2024.
  • Propanc Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -1.76K %, a 9.65% increase year-over-year.
  • Propanc Biopharma, Inc. annual Return On Assets for 2024 was -1.37K %, a 47.7% increase from 2023.
  • Propanc Biopharma, Inc. annual Return On Assets for 2023 was -2.62K %, a 4.31% decline from 2022.
  • Propanc Biopharma, Inc. annual Return On Assets for 2022 was -2.51K %, a 50.6% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -1.76K +188 +9.65% Jul 1, 2024 Sep 30, 2024
Q2 2024 -1.37K +1.25K +47.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.7K +935 +35.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.59K +587 +26.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.94K +501 +20.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.62K -108 -4.31% Apr 1, 2023 Jun 30, 2023
Q1 2023 -2.64K +219 +7.68% Jan 1, 2023 Mar 31, 2023
Q4 2022 -2.18K +2.48K +53.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.45K +3.37K +57.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -2.51K +2.58K +50.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.85K -2.78K -3967% Jan 1, 2022 Mar 31, 2022
Q4 2021 -4.66K -1.51K -47.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -5.81K -1K -20.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -5.09K -631 -14.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -70.2 +6.97K +99% Jan 1, 2021 Mar 31, 2021
Q4 2020 -3.15K +398 +11.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -4.81K -3.2K -199% Jul 1, 2020 Sep 30, 2020
Q2 2020 -4.46K -2.47K -124% Apr 1, 2020 Jun 30, 2020
Q1 2020 -7.04K -5.06K -255% Jan 1, 2020 Mar 31, 2020
Q4 2019 -3.55K -894 -33.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.61K +5.74K +78.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.99K +3.95K +66.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.98K +3.85K +66% Jan 1, 2019 Mar 31, 2019
Q4 2018 -2.66K +3.96K +59.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -7.35K +581 +7.32% Jul 1, 2018 Sep 30, 2018
Q2 2018 -5.94K +941 +13.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -5.83K -924 -18.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -6.61K -4.91K -288% Oct 1, 2017 Dec 31, 2017
Q3 2017 -7.93K -6.88K -657% Jul 1, 2017 Sep 30, 2017
Q2 2017 -6.88K -5.9K -598% Apr 1, 2017 Jun 30, 2017
Q1 2017 -4.91K -4.08K -495% Jan 1, 2017 Mar 31, 2017
Q4 2016 -1.7K -730 -75.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.05K +23.4 +2.18% Jul 1, 2016 Sep 30, 2016
Q2 2016 -987 +325 +24.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -825 +539 +39.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -972 +1.62K +62.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -1.07K +1.28K +54.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -1.31K +707 +35% Apr 1, 2015 Jun 30, 2015
Q1 2015 -1.36K +5.02K +78.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -2.59K +5.25K +67% Oct 1, 2014 Dec 31, 2014
Q3 2014 -2.35K +8.35K +78% Jul 1, 2014 Sep 30, 2014
Q2 2014 -2.02K +10.7K +84.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -6.38K +10.4K +62% Jan 1, 2014 Mar 31, 2014
Q4 2013 -7.84K -6.67K -573% Oct 1, 2013 Dec 31, 2013
Q3 2013 -10.7K -10.2K -2046% Jul 1, 2013 Sep 30, 2013
Q2 2013 -12.7K Apr 1, 2013 Jun 30, 2013
Q1 2013 -16.8K Jan 1, 2013 Mar 31, 2013
Q4 2012 -1.16K Oct 1, 2012 Dec 31, 2012
Q3 2012 -498 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.